| Pharmaceuticals Industry | Healthcare Sector | Mr. Rodolfo Hrosz CEO | XNSE Exchange | INE058A01010 ISIN |
| IN Country | - Employees | 7 Nov 2025 Last Dividend | 23 Sep 1994 Last Split | - IPO Date |
Sanofi India Limited is a prominent pharmaceutical company focused on manufacturing and trading a wide range of drugs and pharmaceutical products not only within India but also internationally, extending its reach to renowned markets such as Singapore. The company boasts an expansive portfolio of pharmaceutical products across multiple therapeutic domains including diabetes, cardiology, thrombosis, and more. Originally known as Aventis Pharma Limited, the entity underwent a rebranding to Sanofi India Limited in May 2012, marking a significant milestone in its history. With a foundation laid in 1956, Sanofi India Limited operates with its headquarters positioned in Mumbai, India, functioning under the parent company Hoechst GmbH. Furthermore, the company is known for its active engagement in exporting pharmaceutical products, showcasing its global significance in the pharmaceutical industry.
Sanofi India Limited offers a comprehensive array of pharmaceutical products spanning various therapeutic areas. The company's dedication to healthcare is reflected through its high-quality products, which include:
These products are distributed through independent channels, ensuring their availability to a wide patient base. Furthermore, Sanofi India Limited's commitment to health extends beyond the domestic market, with a strong focus on exporting its pharmaceutical solutions, thereby contributing significantly to global health advancements.